Rizvi Syed Ali-aamir bought RCKT
February 11, 2026 · Form 4 insider transaction
Rizvi Syed Ali-aamir bought 61,963 shares of Rocket Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
61,963
Price
$0.00
Total value
N/A
InsiderRizvi Syed Ali-aamir
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after407,874
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.; Represents RSUs, one-third (1/3) of which will become fully vested on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years.